Controlled-rate freezer cryopreservation of highly concentrated peripheral blood mononuclear cells results in higher cell yields and superior autologous T-cell stimulation for dendritic cell-based immunotherapy

Cancer Immunology, Immunotherapy

Volumn 61, Issue 11, 2012, Pages 2021-2031

  Buhl, Timo ^a   Legler, Tobias J ^a   Rosenberger, Albert ^a   Schardt, Anke ^a   Schön, Michael P ^a   Haenssle, Holger A ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Cell yields; Cellular immunotherapy; Cryopreservation; DC; Dendritic cells

Indexed keywords

2 PROPANOL; CYTOKINE; GAMMA INTERFERON;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL VIABILITY; CONTROLLED RATE FREEZER CRYOPRESERVATION; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE RELEASE; DENDRITIC CELL BASED IMMUNOTHERAPY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; THAWING;

2-PROPANOL; BLOOD PRESERVATION; CELL SURVIVAL; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY; LEUKAPHERESIS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS;

EID: 84871010600     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1262-0     Document Type: Article

References (45)

1. Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature 449:419-426
2. Trombetta ES, Mellman I (2005) Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23:975-1028
3. Palucka K, Ueno H, Banchereau J (2011) Recent developments in cancer vaccines. J Immunol 186:1325-1331
4. Finn OJ (2008) Cancer immunology. N Engl J Med 358:2704-2715
5. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF et al (2010) Sipuleucel-T immunotherapy for castrationresistant prostate cancer. N Engl J Med 363:411-422
6. Boscardin SB, Hafalla JC, Masilamani RF, Kamphorst AO, Zebroski HA, Rai U et al (2006) Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J Exp Med 203:599-606
7. Thomson AW, Robbins PD (2008) Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann Rheum Dis 67(Suppl 3):iii90-iii96
8. Rinaldo CR (2009) Dendritic cell-based human immunodeficiency virus vaccine. J Intern Med 265:138-158
9. Feuerstein B, Berger TG, Maczek C, Roder C, Schreiner D, Hirsch U et al (2000) A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J Immunol Methods 245:15-29
10. Garritsen HS, Macke L, Meyring W, Hannig H, Pagelow U, Wormann B et al (2010) Efficient generation of clinical-grade genetically modified dendritic cells for presentation of multiple tumor-associated proteins. Transfusion 50:831-842
11. John J, Dalgleish A, Melcher A, Pandha H (2005) Cryopreserved dendritic cells for intratumoral immunotherapy do not require re-culture prior to human vaccination. J Immunol Methods 299: 37-46
12. Hayden H, Friedl J, Dettke M, Sachet M, Hassler M, Dubsky P et al (2009) Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy. J Immunother 32:638-654
13. Meryman HT (1956) Mechanics of freezing in living cells and tissues. Science 124:515-521
14. Pegg DE (2002) The history and principles of cryopreservation. Semin Reprod Med 20:5-13
15. Meryman HT (2007) Cryopreservation of living cells: Principles and practice. Transfusion 47:935-945
16. Perez-Oteyza J, Bornstein R, Corral M, Hermosa V, Alegre A, Torrabadella M et al (1998) Controlled-rate versus uncontrolledrate cryopreservation of peripheral blood progenitor cells: A prospective multicenter study. Group for cryobiology and biology of bone marrow transplantation (CBTMO), Spain. Haematologica 83:1001-1005
17. Montanari M, Capelli D, Poloni A, Massidda D, Brunori M, Spitaleri L et al (2003) Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: A comparison between controlled-rate freezing and uncontrolledrate freezing at 80 °C. Transfusion 43:42-49
18. Bakken AM (2006) Cryopreserving human peripheral blood progenitor cells. Curr Stem Cell Res Ther 1:47-54
19. Wolf CE, Meyer M, Riggert J (2005) Leukapheresis for the extraction of monocytes and various lymphocyte subpopulations from peripheral blood: Product quality and prediction of the yield using different harvest procedures. Vox Sang 88:249-255
20. Haenssle H, Buhl T, Knudsen S, Krueger U, Rosenberger A, Reich K et al (2008) CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes. Exp Dermatol 17:177-187
21. Brunner E, Domhof S, Langer F (2002) Nonparametric analysis of longitudinal data in factorial experiments. Wiley, New York
22. Verdijk P, Aarntzen EH, Lesterhuis WJ, Boullart AC, Kok E, van Rossum MM et al (2009) Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin Cancer Res 15:2531-2540
23. Draube A, Klein-Gonzalez N, Mattheus S, Brillant C, Hellmich M, Engert A et al (2011) Dendritic cell based tumor vaccination in prostate and renal cell cancer: A systematic review and metaanalysis. PLoS ONE 6:e18801
24. Engell-Noerregaard L, Hansen TH, Andersen MH, Thor Straten P, Svane IM (2009) Review of clinical studies on dendritic cellbased vaccination of patients with malignant melanoma: Assessment of correlation between clinical response and vaccine parameters. Cancer Immunol Immunother 58:1-14
25. Lesterhuis WJ, De Vries IJ, Schreibelt G, Schuurhuis DH, Aarntzen EH, De Boer A et al (2010) Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients. Anticancer Res 30:5091-5097
26. Schadendorf D, Ugurel S, Schuler-Thurner B, Nestle FO, Enk A, Brocker EB et al (2006) Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: A randomized phase III trial of the DC study group of the DeCOG. Ann Oncol 17:563-570
27. Ribas A, Comin-Anduix B, Chmielowski B, Jalil J, de la Rocha P, McCannel TA et al (2009) Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin Cancer Res 15:6267-6276
28. Rollig C, Schmidt C, Bornhauser M, Ehninger G, Schmitz M, Auffermann-Gretzinger S (2011) Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells. J Immunother 34:100-106
29. Yi Q, Szmania S, Freeman J, Qian J, Rosen NA, Viswamitra S et al (2010) Optimizing dendritic cell-based immunotherapy in multiple myeloma: Intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients. Br J Haematol 150:554-564
30. Tuyaerts S, Aerts JL, Corthals J, Neyns B, Heirman C, Breckpot K et al (2007) Current approaches in dendritic cell generation and future implications for cancer immunotherapy. Cancer Immunol Immunother 56:1513-1537
31. Vuckovic S, Clark GJ, Hart DN (2002) Growth factors, cytokines and dendritic cell development. Curr Pharm Des 8:405-418
32. Suen Y, Lee SM, Aono F, Hou S, Loudovaris M, Ofstein G et al (2001) Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC. Cytotherapy 3:365-375
33. Felzmann T, Witt V, Wimmer D, Ressmann G, Wagner D, Paul P et al (2003) Monocyte enrichment from leukapheresis products for the generation of DCs by plastic adherence, or by positive or negative selection. Cytotherapy 5:391-398
34. Meyer-Wentrup F, Burdach S (2003) Efficacy of dendritic cell generation for clinical use: Recovery and purity of monocytes and mature dendritic cells after immunomagnetic sorting or adherence selection of CD14? starting populations. J Hematother Stem Cell Res 12:289-299
35. Perseghin P, D'Amico G, Dander E, Gaipa G, Dassi M, Biagi E et al (2008) Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device. Transfusion 48:1644-1649
36. Breckpot K, Corthals J, Heirman C, Bonehill A, Michiels A, Tuyaerts S et al (2004) Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cells. Hum Gene Ther 15:562-573
37. Elkord E, Williams PE, Kynaston H, Rowbottom AW (2005) Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology 114: 204-212
38. Heo YJ, Son CH, Chung JS, Park YS, Son JH (2009) The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy. Cryobiology 58:203-209
39. Spertini O, Luscinskas FW, Gimbrone MA Jr, Tedder TF (1992) Monocyte attachment to activated human vascular endothelium in vitro is mediated by leukocyte adhesion molecule-1 (L-selectin) under nonstatic conditions. J Exp Med 175:1789-1792
40. De Boer F, Drager AM, Van der Wall E, Pinedo HM, Schuurhuis GJ (1998) Changes in L-selectin expression on CD34-positive cells upon cryopreservation of peripheral blood stem cell transplants. Bone Marrow Transpl 22:1103-1110
41. Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R et al (2009) Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol 16:1176-118642. Kleeberger CA, Lyles RH, Margolick JB, Rinaldo CR, Phair JP, Giorgi JV (1999) Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin Diagn Lab Immunol 6:14-19
42. Haenssle HA, Riedl P, Buhl T, Schardt A, Rosenberger A, Schoǒn MP et al (2010) Intracellular delivery of major histocompatibility complex class I-binding epitopes: Dendritic cells loaded and matured with cationic peptide/poly(I:C) complexes efficiently activate T cells. Exp Dermatol 19:19-28
43. Alvarez D, Vollmann EH, von Andrian UH (2008) Mechanisms and consequences of dendritic cell migration. Immunity 29:325-342
44. Westermann J, Korner IJ, Kopp J, Kurz S, Zenke M, Dorken B et al (2003) Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: Influence on phenotype and functional properties. Cancer Immunol Immunother 52:194-198
45. Hori S, Heike Y, Takei M, Maruyama M, Inoue Y, Lee JJ et al (2004) Freeze-thawing procedures have no influence on the phenotypic and functional development of dendritic cells generated from peripheral blood CD14? monocytes. J Immunother 27:27-35